Index by author
Proceedings of the 1st World Congress on Controversies in Diabetes, Obesity and Hypertension (CODHy)
February 01 2008; volume 31 issue Supplement 2
B
Basi, Seema
- You have accessRestricted AccessMicroalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
Beattie, Scott D.
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Bianchi, Cristina
- You have accessRestricted AccessPrimary Prevention of Cardiovascular Disease in People With DysglycemiaCristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
Bloom, Stephen R.
- You have accessRestricted AccessCan Gut Hormones Control Appetite and Prevent Obesity?Owais B. Chaudhri, Katie Wynne and Stephen R. Bloom
Bolli, Geremia B.
- You have accessRestricted AccessPrevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogsPaolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
Brendel, Mathias D.
- You have accessRestricted AccessIs Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
Bretzel, Reinhard G.
- You have accessRestricted AccessIs Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
C
Campaigne, Barbara N.
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Ceriello, Antonio
- You have accessRestricted AccessPossible Role of Oxidative Stress in the Pathogenesis of HypertensionAntonio Ceriello
Chaudhri, Owais B.
- You have accessRestricted AccessCan Gut Hormones Control Appetite and Prevent Obesity?Owais B. Chaudhri, Katie Wynne and Stephen R. Bloom
Colette, Claude
- You have accessRestricted AccessGlycemic VariabilityShould we and can we prevent it?Louis Monnier and Claude Colette
D
Dankner, Rachel
- You have accessRestricted AccessInsulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
Del Prato, Stefano
- You have accessRestricted AccessPrimary Prevention of Cardiovascular Disease in People With DysglycemiaCristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
Després, Jean-Pierre
- You have accessRestricted AccessEfficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) programLuc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
de Zeeuw, Dick
- You have accessRestricted AccessAlbuminuria: A Great Risk Marker, but an Underestimated Target in DiabetesDick de Zeeuw and Itamar Raz
Donath, Marc Y.
- You have accessRestricted AccessIslet Inflammation in Type 2 DiabetesFrom metabolic stress to therapyMarc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
E
Ehses, Jan A.
- You have accessRestricted AccessIslet Inflammation in Type 2 DiabetesFrom metabolic stress to therapyMarc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
Ellingsgaard, Helga
- You have accessRestricted AccessIslet Inflammation in Type 2 DiabetesFrom metabolic stress to therapyMarc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
F
Fanelli, Carmine G.
- You have accessRestricted AccessPrevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogsPaolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
Faulenbach, Mirjam
- You have accessRestricted AccessIslet Inflammation in Type 2 DiabetesFrom metabolic stress to therapyMarc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
Fesler, Pierre
- You have accessRestricted AccessMicroalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
G
Galic, Edvard
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Gitt, Anselm K.
- You have accessRestricted AccessShould We Prescribe Statin and Aspirin for Every Diabetic Patient?Is it time for a polypill?Harm Wienbergen, Jochen Senges and Anselm K. Gitt
Gromniak, Elwira
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Grossman, Ehud
H
Hainer, Vojtĕch
- You have accessRestricted AccessTreatment Modalities of ObesityWhat fits whom?Vojtĕch Hainer, Hermann Toplak and Asimina Mitrakou
Hanefeld, Markolf
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Hardt, Philip D.
- You have accessRestricted AccessIs Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
K
Kaufman, Francine Ratner
- You have accessRestricted AccessMetabolic Complications of Childhood ObesityIdentifying and mitigating the riskRam Weiss and Francine Ratner Kaufman
Kloer, Hans U.
- You have accessRestricted AccessIs Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?Philip D. Hardt, Mathias D. Brendel, Hans U. Kloer and Reinhard G. Bretzel
Kowalska, Irina
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
L
Lewis, Edmund J.
- You have accessRestricted AccessAbnormal Glomerular Permeability Characteristics in Diabetic NephropathyImplications for the therapeutic use of low–molecular weight heparinEdmund J. Lewis and Xiulong Xu
Lewis, Julia B.
- You have accessRestricted AccessMicroalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
M
Massi-Benedetti, Massimo
- You have accessRestricted AccessTreatment of Type 2 Diabetes With Combined TherapyWhat are the pros and cons?Massimo Massi-Benedetti and Marco Orsini-Federici
McCarthy, Christine
- You have accessRestricted AccessEfficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) programLuc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
Miccoli, Roberto
- You have accessRestricted AccessPrimary Prevention of Cardiovascular Disease in People With DysglycemiaCristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
Milicevic, Zvonko
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Mimran, Albert
- You have accessRestricted AccessMicroalbuminuria in Type 2 Diabetes and HypertensionA marker, treatment target, or innocent bystander?Seema Basi, Pierre Fesler, Albert Mimran and Julia B. Lewis
Mitrakou, Asimina
- You have accessRestricted AccessTreatment Modalities of ObesityWhat fits whom?Vojtĕch Hainer, Hermann Toplak and Asimina Mitrakou
Monnier, Louis
- You have accessRestricted AccessGlycemic VariabilityShould we and can we prevent it?Louis Monnier and Claude Colette
Morton, John M.
- You have accessRestricted AccessBariatric Surgery in Patients With Morbid Obesity and Type 2 DiabetesGuntram Schernthaner and John M. Morton
N
Nilsson, Peter M.
- You have accessRestricted AccessIs Weight Loss Beneficial for Reduction of Morbidity and Mortality?What is the controversy about?Peter M. Nilsson
O
Orsini-Federici, Marco
- You have accessRestricted AccessTreatment of Type 2 Diabetes With Combined TherapyWhat are the pros and cons?Massimo Massi-Benedetti and Marco Orsini-Federici
Osher, Etty
- You have accessRestricted AccessDiastolic Pressure in Type 2 DiabetesCan target systolic pressure be reached without “diastolic hypotension”?Etty Osher and Naftali Stern
P
Paravicini, Tamara M.
- You have accessRestricted AccessNADPH Oxidases, Reactive Oxygen Species, and HypertensionClinical implications and therapeutic possibilitiesTamara M. Paravicini and Rhian M. Touyz
Penno, Giuseppe
- You have accessRestricted AccessPrimary Prevention of Cardiovascular Disease in People With DysglycemiaCristina Bianchi, Roberto Miccoli, Giuseppe Penno and Stefano Del Prato
Perren, Aurel
- You have accessRestricted AccessIslet Inflammation in Type 2 DiabetesFrom metabolic stress to therapyMarc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
Phillip, Moshe
- You have accessRestricted AccessHypoglycemia in Type 1 DiabetesA still unresolved problem in the era of insulin analogs and pump therapyShlomit Shalitin and Moshe Phillip
Pi-Sunyer, Xavier
- You have accessRestricted AccessEfficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) programLuc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
Pickup, John C.
- You have accessRestricted AccessLong-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 DiabetesJohn C. Pickup and Eric Renard
Pillar, Giora
- You have accessRestricted AccessAbdominal Fat and Sleep ApneaThe chicken or the egg?Giora Pillar and Naim Shehadeh
Porcellati, Francesca
- You have accessRestricted AccessPrevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogsPaolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
R
Raz, Itamar
- You have accessRestricted AccessThe Controversies in Obesity, Diabetes and Hypertension (CODHy) MeetingWhat is it all about?Itamar Raz and Ram Weiss
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
- You have accessRestricted AccessAlbuminuria: A Great Risk Marker, but an Underestimated Target in DiabetesDick de Zeeuw and Itamar Raz
Renard, Eric
- You have accessRestricted AccessLong-Acting Insulin Analogs Versus Insulin Pump Therapy for the Treatment of Type 1 and Type 2 DiabetesJohn C. Pickup and Eric Renard
Riddle, Matthew C.
- You have accessRestricted AccessCombined Therapy With Insulin Plus Oral Agents: Is There Any Advantage?An argument in favorMatthew C. Riddle
Rossetti, Paolo
- You have accessRestricted AccessPrevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 DiabetesThe role of insulin analogsPaolo Rossetti, Francesca Porcellati, Geremia B. Bolli and Carmine G. Fanelli
Roth, Jesse
- You have accessRestricted AccessInsulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
Rubino, Francesco
- You have accessRestricted AccessIs Type 2 Diabetes an Operable Intestinal Disease?A provocative yet reasonable hypothesisFrancesco Rubino
S
Sarwat, Samiha
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Scheen, André
- You have accessRestricted AccessEfficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) programLuc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
Schernthaner, Guntram
- You have accessRestricted AccessBariatric Surgery in Patients With Morbid Obesity and Type 2 DiabetesGuntram Schernthaner and John M. Morton
Schnell, Oliver
- You have accessRestricted AccessInsulin as a First-Line Therapy in Type 2 DiabetesShould the use of sulfonylureas be halted?Eberhard Standl and Oliver Schnell
Schumann, Desiree M.
- You have accessRestricted AccessIslet Inflammation in Type 2 DiabetesFrom metabolic stress to therapyMarc Y. Donath, Desiree M. Schumann, Mirjam Faulenbach, Helga Ellingsgaard, Aurel Perren and Jan A. Ehses
Senges, Jochen
- You have accessRestricted AccessShould We Prescribe Statin and Aspirin for Every Diabetic Patient?Is it time for a polypill?Harm Wienbergen, Jochen Senges and Anselm K. Gitt
Shalitin, Shlomit
- You have accessRestricted AccessHypoglycemia in Type 1 DiabetesA still unresolved problem in the era of insulin analogs and pump therapyShlomit Shalitin and Moshe Phillip
Shanik, Michael H.
- You have accessRestricted AccessInsulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
Shehadeh, Naim
- You have accessRestricted AccessAbdominal Fat and Sleep ApneaThe chicken or the egg?Giora Pillar and Naim Shehadeh
Škrha, Jan
- You have accessRestricted AccessInsulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
Standl, Eberhard
- You have accessRestricted AccessInsulin as a First-Line Therapy in Type 2 DiabetesShould the use of sulfonylureas be halted?Eberhard Standl and Oliver Schnell
Stern, Naftali
- You have accessRestricted AccessDiastolic Pressure in Type 2 DiabetesCan target systolic pressure be reached without “diastolic hypotension”?Etty Osher and Naftali Stern
Stirban, Alin O.
- You have accessRestricted AccessCardiovascular Complications in DiabetesTargets and interventionsAlin O. Stirban and Diethelm Tschoepe
- You have accessRestricted AccessShould We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?Alin O. Stirban and Diethelm Tschoepe
T
Tan, Meng
- You have accessRestricted AccessNatural History of Cardiovascular Disease in Patients With DiabetesRole of hyperglycemiaZvonko Milicevic, Itamar Raz, Scott D. Beattie, Barbara N. Campaigne, Samiha Sarwat, Elwira Gromniak, Irina Kowalska, Edvard Galic, Meng Tan and Markolf Hanefeld
Tomkin, Gerald H.
- You have accessRestricted AccessTargets for Intervention in Dyslipidemia in DiabetesGerald H. Tomkin
Toplak, Hermann
- You have accessRestricted AccessTreatment Modalities of ObesityWhat fits whom?Vojtĕch Hainer, Hermann Toplak and Asimina Mitrakou
Touyz, Rhian M.
- You have accessRestricted AccessNADPH Oxidases, Reactive Oxygen Species, and HypertensionClinical implications and therapeutic possibilitiesTamara M. Paravicini and Rhian M. Touyz
Tschoepe, Diethelm
- You have accessRestricted AccessCardiovascular Complications in DiabetesTargets and interventionsAlin O. Stirban and Diethelm Tschoepe
- You have accessRestricted AccessShould We Be More Aggressive in the Therapy Against Cardiovascular Risk Factors?Should we prescribe statin and aspirin for every diabetic patient, or is it time for a polypill?Alin O. Stirban and Diethelm Tschoepe
V
Van Gaal, Luc
- You have accessRestricted AccessEfficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese PatientsPooled 1-year data from the Rimonabant in Obesity (RIO) programLuc Van Gaal, Xavier Pi-Sunyer, Jean-Pierre Després, Christine McCarthy and André Scheen
W
Weiss, Ram
- You have accessRestricted AccessMetabolic Complications of Childhood ObesityIdentifying and mitigating the riskRam Weiss and Francine Ratner Kaufman
- You have accessRestricted AccessThe Controversies in Obesity, Diabetes and Hypertension (CODHy) MeetingWhat is it all about?Itamar Raz and Ram Weiss
Wienbergen, Harm
- You have accessRestricted AccessShould We Prescribe Statin and Aspirin for Every Diabetic Patient?Is it time for a polypill?Harm Wienbergen, Jochen Senges and Anselm K. Gitt
Wolpert, Howard A.
- You have accessRestricted AccessThe Nuts and Bolts of Achieving End Points With Real-Time Continuous Glucose MonitoringHoward A. Wolpert
Wynne, Katie
- You have accessRestricted AccessCan Gut Hormones Control Appetite and Prevent Obesity?Owais B. Chaudhri, Katie Wynne and Stephen R. Bloom
X
Xu, Xiulong
- You have accessRestricted AccessAbnormal Glomerular Permeability Characteristics in Diabetic NephropathyImplications for the therapeutic use of low–molecular weight heparinEdmund J. Lewis and Xiulong Xu
Xu, Yuping
- You have accessRestricted AccessInsulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth
Z
Zick, Yehiel
- You have accessRestricted AccessInsulin Resistance and HyperinsulinemiaIs hyperinsulinemia the cart or the horse?Michael H. Shanik, Yuping Xu, Jan Škrha, Rachel Dankner, Yehiel Zick and Jesse Roth

In this Issue
February 2008, 31(Supplement 2)
